Old Web
English
Sign In
Acemap
>
authorDetail
>
James Sherwood
James Sherwood
Takeda Pharmaceutical Company
Norovirus
Antibody
Medicine
Immunology
Virology
3
Papers
62
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy of an intramuscular bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate in healthy US adults.
2020
Vaccine
James Sherwood
Paul M. Mendelman
Eric E. Lloyd
Mengya Liu
John Boslego
Astrid Borkowski
Ashley Jackson
Dennis J. Faix
Show All
Source
Cite
Save
Citations (12)
Antibody persistence to two Virus-Like Particle norovirus vaccine candidate formulations in healthy adults: one-year follow-up with memory probe vaccination
2019
The Journal of Infectious Diseases
Robert L. Atmar
Frank Baehner
Jakob P Cramer
Eric E. Lloyd
James Sherwood
Astrid Borkowski
Paul M. Mendelman
Show All
Source
Cite
Save
Citations (9)
Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial
2018
The Journal of Infectious Diseases
Geert Leroux-Roels
Jakob P Cramer
Paul M. Mendelman
James Sherwood
Ralf Clemens
Annelies Aerssens
Ilse De Coster
Astrid Borkowski
Frank Baehner
Pierre Van Damme
Show All
Source
Cite
Save
Citations (41)
1